Bristol-Myers wins $752 million in U.S. patent case against Gilead
December 13, 2019 at 17:31 PM EST
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
